EUVIMEDEUVIMED entdecken
Crossref

Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy

Almog Ben-Yaacov, Olivia Levine, Gal Schtrechman, Mohammad Adileh, Tamar Beller, Ben Boursi, Naama Halpern, Adam Goldstein, Gil Ben-Yakov, Aviram Nissan, Shachar Laks iD

World Journal of Surgery · 2024

DOI: 10.1002/wjs.12080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgery, 2024. Verfasst von Almog Ben-Yaacov und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery C and Surgical Oncology, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Colorectal Neoplasms, Cytoreduction Surgical Procedures, Hyperthermic Intraperitoneal Chemotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal peritoneal metastases are a devastating consequence of colorectal cancer (CRC) with extremely poor prognosis. Patients that can undergo complete cytoreduction by cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) have a markedly improved overall survival. Traditionally, patients with extremely high peritoneal cancer index (PCI), PCI >20, are not offered CRS/HIPEC.

Methods

We performed a retrospective analysis of our prospectively maintained CRS/HIPEC database and evaluated all patients with CRC peritoneal metastases between 2012 and 2022. We divided the cohorts between those with low operative PCI (PCI20). We examined demographic, clinicopathologic data, perioperative, and oncological outcomes between the cohorts.

Results

Of the 691 patients who underwent CRS/HIPEC, 289 were evaluable with CRC metastases, 234 with PCI 20. Median radiologic preoperative and operative PCI was 4 and 10 versus 7 and 24.5 in the low and high PCI cohorts, respectively. Operative time was longer (6 vs. 4 h) and blood loss higher (500 vs. 400 mL) in the high PCI cohort. All other demographic, clinicopathological, and operative characteristics were similar. Median disease free survival (DFS) was longer in the low PCI cohort (11.5 vs. 7 months) but overall survival (OS) showed benefit (41.3 vs. 31.8 months), ( p = 0.001 and p = 0.189, respectively), comparatively with an only chemotherapy strategy.

Conclusions

Appropriately selected patients with CRC metastases and extremely high PCI demonstrate similar perioperative safety outcomes in experienced tertiary referral centers. Despite a shorter median DFS, these carefully selected patients demonstrated similar median OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsColorectal NeoplasmsCytoreduction Surgical ProceduresHyperthermic Intraperitoneal ChemotherapyHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAdultSurvival RateTreatment OutcomeCombined Modality TherapyPatient Selection

Stichwörter der Autor:innen

colorectal cancercytoreductive surgeryheated intraperitoneal chemotherapyperitoneal cancer index

Autor:innen und Institutionen

  • Department of General Surgery C and Surgical Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Tel-Aviv University, Tel-Aviv, Israel.
  • Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Department of Surgery A, Edith Wolfson Medical Center, Holon, Israel.
  • Department of Gastroenterology, Edith Wolfson Medical Center, Holon, Israel.

ORCID-Profile: Shachar Laks

Zitieren

APA

Ben-Yaacov, A., Levine, O., Schtrechman, G., Adileh, M., Beller, T., Boursi, B., Halpern, N., Goldstein, A., Ben-Yakov, G., Nissan, A., & Laks, S. (2024). Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. World Journal of Surgery. https://doi.org/10.1002/wjs.12080

Vancouver

Ben-Yaacov A, Levine O, Schtrechman G, Adileh M, Beller T, Boursi B, et al. Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. World Journal of Surgery. 2024. doi:10.1002/wjs.12080

BibTeX
@article{BenYaacov2024,
  author = {Ben-Yaacov, Almog and Levine, Olivia and Schtrechman, Gal and Adileh, Mohammad and Beller, Tamar and Boursi, Ben and Halpern, Naama and Goldstein, Adam and Ben-Yakov, Gil and Nissan, Aviram and Laks, Shachar},
  title = {Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy},
  journal = {World Journal of Surgery},
  year = {2024},
  doi = {10.1002/wjs.12080}
}
Kostenlos starten →